Donate today and join the fight to achieve global malaria elimination targets.
Together we can make a significant contribution to achieving malaria elimination targets.
Improving the health of vulnerable communities and changing lives is at the heart of what we do and who we are.
There are over 500-750,000 deaths per year due to HBV-related cirrhosis and liver cancer worldwide and the WHO Western Pacific Region has some of the highest endemic levels of hepatitis B (HBV) in the world, particularly within China, South East Asia and Pacific Island Countries and Territories (PICT). The PICT have unique ethnic diversity and a very high prevalence of smoking and the metabolic syndrome, both important risk factors for liver fibrosis and liver cancer. However, in contrast to many Asian countries there is little published data on HBV prevalence and related liver disease burden in PICT. In this review, the available published literature and WHO data for HBV prevalence and related liver disease and liver cancer burden in PICT is outlined and unmet needs for improving HBV prevention and control in the region are highlighted.
To achieve better health for vulnerable communities in Australia and internationally by accelerating the translation of research, discovery and evidence into sustainable health solutions.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2022 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung people and we offer our respects to their Elders past and present.
We recognise and respect the continuation of cultural, spiritual and educational practices of Aboriginal and Torres Strait Islander peoples of this land.
